Regulatory Newsletter

This quarterly newsletter is dedicated to news about ISPE’s regulatory and quality activities. ISPE is committed to fostering communications and interactions to advance common interests among the pharmaceutical industry and regulatory agencies. ISPE provides a neutral environment where our individual Members and experts belonging to Health Authorities can engage in open dialogue on issues that will ultimately benefit patients around the world.

Regulatory Newsletter
ISPE is committed to fostering communications and interactions to advance common interests among the pharmaceutical industry and regulatory agencies. Regulator/Industry Panels at ISPE European Annual Conference A panel...
Regulatory Newsletter
ISPE is committed to fostering communications and interactions to advance common interests among the pharmaceutical industry and regulatory agencies. Industry Study Finds Divergence in Regulators’ Interpretation of ICH...
Regulatory Newsletter
ISPE is committed to fostering communications and interactions to advance common interests among the pharmaceutical industry and regulatory agencies. US FDA and WHO Highlight Agility and Collaboration at ISPE Annual...
Regulatory Newsletter
ISPE is committed to fostering communications and interactions to advance common interests among the pharmaceutical industry and regulatory agencies. Global Regulators and Industry discuss Shared Responsibility for QRM...
Regulatory Newsletter
Introducing ISPE’s Regulatory Digest This new quarterly newsletter is dedicated to news about ISPE’s regulatory and quality activities. ISPE is committed to fostering communications and interactions to advance common...
Regulatory Newsletter
This quarterly newsletter is dedicated to news about ISPE’s regulatory and quality activities. ISPE is committed to fostering communications and interactions to advance common interests among the pharmaceutical industry...